02 May 2003
Poly(ADP-ribosyl)ation, DNA repair and life span
A. Bürkle, S. Beneke, C. Brabeck, A. Leake, R. Meyer, M. L. Muiras, R. PfeifferMed Sci Monit 2003; 9(1): 5-0 :: ID: 14990
Abstract
Poly(ADP-ribosyl)ation is functionally associated with DNA base-excision repair and is a survival factor and negative regulator of genomic instability in cells under low to moderate levels of genotoxic stress [1]. Previously we have described a positive correlation between poly(ADP-ribosyl)ation capacity of mononuclear blood cells with longevity of mammalian species [2]. Our subsequent comparisons of purified recombinant human and rat PARP-1 revealed that this correlation might be explained in part by evolutionary sequence divergence [3]. We have also reported an association of high poly(ADP-ribosyl)ation capacity of lymphoblastoid cell cultures with longevity of human donors [4]. Recently we have asked if the efficiency of single strand-break repair in mononuclear blood cells following gamma-radiation might also be related with mammalian life span. We quantified DNA strand breaks both immediately after irradiation and after a defined postincubation (‘repair’) period, using a recently developed automated version of the fluorescence-detected alkaline unwinding assay. Our data reveal the existence of a highly significant positive correlation between the extent of repair and life span of donor species [5]. In another set of experiments we have investigated the possible effects of L-selegiline on the cellular poly(ADP-ribosyl)ation response. L-selegiline is an anti-Parkinson drug, which irreversibly inhibits monoamine oxidase B (MAO-B) but possesses additional effects, such as neuroprotective activity in vivo and in cultured cells and life span-extension in laboratory animals. Intriguingly, our data show that low concentrations of L-selegiline can potentiate the gamma-radiation-induced poly(ADP-ribose) formation in cultured hamster cells [6], thus strengthening the links between poly(ADP-ribosyl)ation, cytoprotection and mammalian longevity.References: 1.Bürkle A: Cancer Lett, 2001; 163: 1-5 2.Grube K, Bürkle A: Proc Natl Acad Sci USA, 1992; 89: 11759-11763 3.Beneke S, Alvarez-Gonzalez R, Bürkle A: Exp Gerontol, 2000; 35: 989-1002 4.Muiras ML, Müller M, Schächter F, Bürkle A: J Mol Med, 1998; 76: 346-354 5.Pfeiffer R, Leake A, Müller M, Kirkwood TB, Bürkle A: manuscript in preparation. 6.Brabeck C, Pfeiffer R, Leake L, Beneke S, Meyer R, Bürkle A: submitted.
Keywords: PARP-1, DNA strand breaks, DNA Repair, ageing, life span, L-selegiline
279 0
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
28 May 2023 : Database Analysis
Scientometric and Visualized Analysis of Intravoxel Incoherent Motion Magnetic Resonance Imaging: 1988-2021Med Sci Monit In Press; DOI: 10.12659/MSM.938715
25 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
25 May 2023 : Review article
A Review of Preclinical and Clinical Studies in Support of the Role of Non-Steroidal Anti-Inflammatory Drug...Med Sci Monit In Press; DOI: 10.12659/MSM.940635
25 May 2023 : Clinical Research
Periapical Lesions and Missed Canals in Endodontically Treated Teeth: A Cone-Beam Computed Tomographic Stud...Med Sci Monit In Press; DOI: 10.12659/MSM.940533
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952